Daily Cardiology Research Analysis
Three studies advance cardiovascular risk stratification and interventional optimization. Urinary kidney tubular biomarkers at admission predicted death or heart failure readmission beyond glomerular metrics in acute heart failure, a quantitative Doppler shape metric (Vmax/Vmean) refined severity and prognosis in functional tricuspid regurgitation, and intracoronary imaging/physiology guidance reduced 1-year target lesion failure in high-risk PCI compared with angiography alone.
Summary
Three studies advance cardiovascular risk stratification and interventional optimization. Urinary kidney tubular biomarkers at admission predicted death or heart failure readmission beyond glomerular metrics in acute heart failure, a quantitative Doppler shape metric (Vmax/Vmean) refined severity and prognosis in functional tricuspid regurgitation, and intracoronary imaging/physiology guidance reduced 1-year target lesion failure in high-risk PCI compared with angiography alone.
Research Themes
- Biomarker-driven prognosis in acute heart failure
- Quantitative echocardiography for valvular disease risk stratification
- Intracoronary imaging/physiology to optimize PCI outcomes
Selected Articles
1. Kidney Tubular Biomarkers Predict Risk of Death and Heart Failure Readmission in Acute Heart Failure.
In a matched case-control cohort within AKINESIS, 14 urinary tubular injury/dysfunction biomarkers measured at admission were associated with death or heart failure readmission independent of glomerular function and cardiac risk markers. Findings shift prognostication beyond eGFR by highlighting tubular health as a key signal in acute heart failure.
Impact: Identifies tubular biomarkers as independent predictors of hard outcomes in acute heart failure, refining risk stratification beyond traditional glomerular metrics.
Clinical Implications: Consider integrating urinary tubular biomarkers at admission to identify high-risk acute heart failure patients for closer monitoring, early post-discharge follow-up, and tailored decongestion/renal-protective strategies.
Key Findings
- Urinary tubular damage/dysfunction biomarkers measured at admission were associated with the composite of death or HF readmission.
- Associations were independent of glomerular function (eGFR) and cardiac risk biomarkers.
- Study included 218 AKI and 218 non-AKI matched patients; 14 tubular biomarkers were profiled at admission.
Methodological Strengths
- Matched case-control design within a defined acute HF cohort with standardized admission sampling.
- Multivariable models adjusted for both renal (glomerular) and cardiac biomarkers to test independence.
Limitations
- Case-control design limits causal inference and may be prone to selection bias.
- Follow-up duration and event adjudication details are not specified in the abstract; biomarker-specific effect sizes are not provided.
Future Directions: Prospective, multicenter validation with predefined thresholds and integration into risk scores; interventional studies testing biomarker-guided decongestion and renal-protective strategies.
BACKGROUND: Kidney dysfunction, defined by measures of glomerular health, in patients hospitalized with acute heart failure (HF) is associated with death and HF readmission. We aimed to determine if kidney tubule damage and dysfunction are associated with these outcomes in acute HF. METHODS: In AKINESIS (Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin [NGAL] Evaluation of Symptomatic Heart Failure Study), 218 individuals admitted with acute HF experiencing acute kidney injury were matched with 218 individuals without acute kidney injury. Fourteen urine tubular damage and dysfunction biomarkers were measured at hospital admission in this case-control cohort. Associations between biomarkers and the composite outcome of death or HF readmission, death alone, and HF readmission alone were evaluated adjusting for confounders including kidney and cardiac biomarkers. RESULTS: The mean age was 71±12 years, 64% were men, and mean admission estimated glomerular filtration rate was 55±23 mL/min per 1.73 m CONCLUSIONS: Biomarkers of kidney tubular health are associated with risk of death and HF readmission among people admitted with acute HF independent of measures of glomerular function and cardiac risk.
2. Quantitative Doppler Shape Analysis in Functional Tricuspid Regurgitation.
In 245 patients with functional tricuspid regurgitation, a simple quantitative ratio (Vmax/Vmean) captured Doppler shape progression from parabolic to v-wave cutoff and independently predicted death or heart failure hospitalization. The metric correlated with effective regurgitant orifice area and RV function, whereas time-to-peak/TR duration was not prognostic.
Impact: Introduces a practical, quantitative Doppler shape parameter that tracks hydraulic severity and predicts outcomes, potentially simplifying risk stratification in functional tricuspid regurgitation.
Clinical Implications: Vmax/Vmean can augment routine echocardiographic assessment of functional TR to flag patients at higher risk for adverse outcomes, informing earlier intervention or closer follow-up even when traditional parameters are borderline.
Key Findings
- Vmax/Vmean increased with TR severity from parabolic (1.26±0.07) to triangular (1.32±0.10) to v-wave cutoff (1.42±0.14; P<.001).
- Vmax/Vmean independently predicted death or HF hospitalization (adjusted HR 1.32; 95% CI 1.09-1.60).
- Time-to-peak velocity corrected for TR duration (TTP/TRD) was not associated with outcomes; Vmax/Vmean’s incremental prognostic value over EROA was not significant in hierarchical models.
Methodological Strengths
- Standardized TR grading (corrected PISA) with both qualitative and quantitative Doppler shape analyses.
- Time-to-event analyses with multivariable Cox modeling and Kaplan–Meier/log-rank testing.
Limitations
- Observational study; external validation and reproducibility across platforms/labs are needed.
- Incremental prognostic value over EROA was not demonstrated; single metric may not replace comprehensive assessment.
Future Directions: Prospective multicenter validation, definition of clinically actionable cut points, and integration into TR grading algorithms and decision-making for timing of intervention.
BACKGROUND: The shape of the continuous-wave Doppler (CWD) envelope in functional tricuspid valve regurgitation (fTR) results from the dynamic interplay between flow, pressure gradient, and impedance. Although the v-wave cutoff shape in fTR is a well-recognized feature of severe tricuspid regurgitation (TR), the complete spectrum of TR CWD shapes across the different fTR severity ranges has not been thoroughly explored, which is the scope of the present study. METHODS: In 245 patients with fTR, TR was graded with transthoracic echocardiography using the corrected proximal isovelocity surface area method, and CWD shapes were scored, both qualitatively (using visual scoring into parabolic, triangular, or v-wave cutoff categories) and quantitatively (using a novel Vmax/Vmean parameter and time-to-peak velocity corrected for TR duration [TTP/TRD]). Linear regression analysis was performed to identify associations of Vmax/Vmean and TTP/TRD. Vmax/Vmean was categorized into tertiles to assess its association with the composite end point of death and heart failure hospitalization. Survival analysis consisted of Kaplan-Meier curves with log-rank tests and a multivariate Cox regression model. RESULTS: The Vmax/Vmean ratio as a surrogate value for fTR CWD shapes increases from a parabolic shape (1.26 ± 0.07) toward a more triangular shape without v-wave (1.32 ± 0.10) and eventually the v-wave cutoff sign (1.42 ± 0.14, P < .001) in most severe fTR. The Vmax, effective regurgitant orifice area, and right ventricular function parameters are significantly associated with Vmax/Vmean and TTP/TRD. Vmax/Vmean is independently associated with the occurrence of the composite end point (adjusted hazard ratio = 1.32; 95% CI, 1.09-1.60 [P = .004], log rank P = .004 between the second [1.27-1.33] and third tertile [>1.33]). Hierarchical Cox models show no incremental value on top of effective regurgitant orifice area (P = .2), whereas TTP/TRD was not associated with outcome. CONCLUSION: Vmax/Vmean reflects the hydraulic severity of fTR and is independently associated with adverse clinical outcomes, providing a simple tool for improved risk stratification in patients with fTR.
3. Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study.
In a multicenter prospective observational study with propensity-matched historical controls, use of intracoronary tools (OCT, IVUS, pressure wire) for stent optimization in high-risk PCI reduced 1-year target lesion failure from 9.3% to 3.4%, driven by fewer target-vessel MIs and ischemia-driven TLRs. Stent thrombosis was numerically lower but not significant.
Impact: Provides real-world, multicenter evidence that individualized intracoronary guidance improves hard clinical endpoints in high-risk PCI, supporting broader adoption where feasible.
Clinical Implications: When available and feasible, employ intracoronary imaging or physiology to optimize stent implantation in complex/high-risk PCI, anticipating reductions in target-vessel MI and repeat lesion revascularization.
Key Findings
- After propensity matching (653 pairs), 1-year target lesion failure was 3.4% with ICT vs 9.3% without ICT (p<0.001).
- Target-vessel MI (0.9% vs 5.6%; p<0.001) and ischemia-driven TLR (1.1% vs 4.6%; p<0.001) were significantly reduced with ICT.
- Stent thrombosis was numerically lower with ICT (0.3% vs 0.9%; p=0.154). OCT (61.4%) and IVUS (22.5%) were the most used tools.
Methodological Strengths
- Prospective, multicenter international cohort with predefined endpoints and propensity-matched comparison.
- Inclusive use of multiple intracoronary modalities reflecting real-world practice.
Limitations
- Nonrandomized design with historical control introduces potential residual confounding and temporal biases.
- Findings may be device- and operator-dependent; generalizability beyond XIENCE-era practice requires caution.
Future Directions: Randomized trials comparing comprehensive intracoronary guidance vs angiography alone in high-risk PCI; cost-effectiveness analyses and implementation pathways.
BACKGROUND: The clinical benefit of using ICT for coronary stent optimization remains uncertain in randomized trials, in which a unique ICT was used in most cases. AIM: To assess the clinical impact of intracoronary techniques (ICT) for stent optimization in high-risk patients. METHODS: The OPTI-XIENCE study is a prospective, observational, multicenter international study including high-risk patients undergoing coronary stenting, in whom any ICT was used for stent optimization at the operator's discretion. The control group was the extended-risk cohort of the XIENCE V USA study, in which no ICT was used. The primary endpoint was the 1-year rate of target lesion failure (TLF), defined as a composite of cardiac death, target-vessel myocardial infarction, or ischemia-driven target lesion revascularization. RESULTS: 753 patients were included. The most frequently used ICT was optical coherence tomography (61.4 %), followed by intravascular ultrasound (22.5 %) and pressure wire in 163 (21.6 %). After propensity score matching with the XIENCE V USA cohort (n = 3179), 653 matched pairs were analyzed. The incidence of TLF at 1 year was significantly lower in the OPTI-XIENCE (3.4 % vs. 9.3 %, p < 0.001), driven by a reduction in target-vessel myocardial infarction (0.9 % vs. 5.6 %, p < 0.001) and ischemia-driven target lesion revascularization (1.1 % vs. 4.6 %, p < 0.001). The incidence of probable or definitive stent thrombosis at 1 year was 0.3 % vs 0.9 %, respectively (p = 0.154). CONCLUSION: The use of any ICT for stent optimization in high-risk PCI significantly improves clinical outcomes compared to angiographic guidance alone. These findings support an individualized use of ICT to optimize complex PCI outcomes.